Belt ndi Road: Mgwirizano, Kugwirizana ndi Win-Win
mankhwala

Zogulitsa

Doxazosin Mesylate CAS: 77883-43-3 Wopanga Wopanga

Doxazosin mesylate ndi quinazoline pawiri kuti ndi kusankha inhibitor wa alpha1 subtype wa alpha adrenergic zolandilira.Doxazosin mesylate ndi mbadwo watsopano wa quinazolone α1 receptor blocker yopangidwa ndi kampani ya Pfizer (United States), Ili ndi theka la moyo wautali, ikuwonetsa zotsatira zake pakukulitsa mitsempha ya magazi, kuchepetsa kukana kwa mitsempha ndi kuchepetsa kuthamanga kwa magazi mwa kutsekereza ndi 1 receptor.Iwo akulimbikitsidwa kunja monga mzere woyamba mankhwala mankhwala odana ndi matenda oopsa ndi mankhwala a prostate matenda.


Tsatanetsatane wa Zamalonda

Zogulitsa Tags

Kugwiritsa Ntchito ndi Zotsatira

Doxazosin mesylate ndi njira yatsopano yosankha α1 receptor blockers, yomwe imakhala ndi zotsatira zazikulu zochepetsera kuthamanga kwa magazi pomwe imakhala ndi zotsatira zabwino zochepetsera lipid metabolism.Ikhoza kuchepetsa kwambiri seramu triglycerides ndi mafuta m'thupi lonse;imathanso kusankha kutsekereza a1 adrenergic cholandilira cha prostate yosalala minofu masanjidwewo, kapisozi ndi chikhodzodzo khosi, kuchepetsa zizindikiro za benign prostatic hyperplasia odwala, kumachepetsa kwambiri kuchepa kwa zotsatira za benign prostatic hyperplasia, makamaka kukhala ndi zotsatira zabwino pa chithandizo cha dysuria. ndi prostatic hyperplasia yosavuta.Lili ndi theka lalitali la moyo. Pakhoza kukhala chizungulire, pakamwa pouma, kupweteka kwa mutu, palpitations, kutopa, zizindikiro ndizochepa, zolekerera, zimatha mkati mwa sabata limodzi, popanda chithandizo chapadera.Palibe postural hypotension yomwe idachitika.

Product Chitsanzo

Chithunzi 79(1)(1)
图片80(3)

Kulongedza katundu:

Chithunzi 81(1)

Zina Zowonjezera:

Kupanga Chithunzi cha C24H29N5O8S
Kuyesa 99%
Maonekedwe White ufa
CAS No. 77883-43-3
Kulongedza 25KG
Shelf Life zaka 2
Kusungirako Sungani pamalo ozizira ndi owuma
Chitsimikizo ISO.

  • Zam'mbuyo:
  • Ena:

  • Lembani uthenga wanu apa ndikutumiza kwa ife